- Home
- ZION vs ASND Comparison
ZION vs ASND Comparison
Compare ZION & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZION
- ASND
- Stock Information
- Founded
- ZION 1873
- ASND 2006
- Country
- ZION United States
- ASND Denmark
- Employees
- ZION N/A
- ASND N/A
- Industry
- ZION Major Banks
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ZION Finance
- ASND Health Care
- Exchange
- ZION Nasdaq
- ASND Nasdaq
- Market Cap
- ZION 8.3B
- ASND 7.7B
- IPO Year
- ZION N/A
- ASND 2015
- Fundamental
- Price
- ZION $53.67
- ASND $136.36
- Analyst Decision
- ZION Hold
- ASND Strong Buy
- Analyst Count
- ZION 18
- ASND 13
- Target Price
- ZION $56.35
- ASND $191.77
- AVG Volume (30 Days)
- ZION 1.3M
- ASND 458.5K
- Earning Date
- ZION 01-21-2025
- ASND 02-05-2025
- Dividend Yield
- ZION 3.21%
- ASND N/A
- EPS Growth
- ZION N/A
- ASND N/A
- EPS
- ZION 4.39
- ASND N/A
- Revenue
- ZION $3,010,000,000.00
- ASND $365,187,374.00
- Revenue This Year
- ZION N/A
- ASND $7.33
- Revenue Next Year
- ZION $3.51
- ASND $83.72
- P/E Ratio
- ZION $12.24
- ASND N/A
- Revenue Growth
- ZION N/A
- ASND 115.54
- 52 Week Low
- ZION $37.76
- ASND $111.09
- 52 Week High
- ZION $63.22
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- ZION 35.68
- ASND 55.65
- Support Level
- ZION $57.68
- ASND $134.53
- Resistance Level
- ZION $59.89
- ASND $141.48
- Average True Range (ATR)
- ZION 1.65
- ASND 5.10
- MACD
- ZION -0.96
- ASND 0.50
- Stochastic Oscillator
- ZION 19.49
- ASND 65.26
About ZION Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.